Five U.S. states sue Purdue Pharma over marketing, selling of opioids By Reuters

Share With Your Friends
Facebook
Twitter
Pinterest
LinkedIn


© Reuters. FILE PHOTO: Bottles of prescription painkiller OxyContin, 40mg, 20mg and 15mg pills, made by Purdue Pharma L.D. sit on a counter at a local pharmacy in Provo

(Reuters) – Five U.S. states on Thursday filed lawsuits accusing Purdue Pharma LP of illegally marketing and selling opioids, including OxyContin, contributing to a nationwide epidemic.

Iowa, Kansas, Maryland, West Virginia and Wisconsin joined 39 other states that have sued Purdue Pharma, Iowa Attorney General Tom Miller said in a statement.

The company’s former president Richard Sackler is also a defendant in some of the lawsuits.

State officials accused Purdue Pharma of repeatedly making false and deceptive claims that opioids, including its OxyContin, were safe for a wide range of patients seeking to reduce pain.

Purdue Pharma had no immediate comment, but was expected to comment later on Thursday.

State and local governments have filed hundreds of lawsuits against companies associated with opioids, including oxycodone and other prescription painkillers.

They have accused drugmakers, including Purdue, of deceptive marketing, and distributors such as AmerisourceBergen (NYSE:) Corp, Cardinal Health Inc (NYSE:) and McKesson Corp (NYSE:) of ignoring how opioids were being used illegally.

Opioids, including prescription painkillers and heroin, played a role in a record 47,600 U.S. overdose deaths in 2017, the U.S. Centers for Disease Control and Prevention has said.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.






Source link

Share With Your Friends
Facebook
Twitter
Pinterest
LinkedIn